M.N. Abed
Inhibition of BCKDK increases the sensitivity of ovarian cancer cells to paclitaxel
Abed, M.N.; Richardson, A.
Citation
Abed, M., & Richardson, A. Inhibition of BCKDK increases the sensitivity of ovarian cancer cells to paclitaxel. Presented at 28 EORTC – NCI – AACR Symposium on Molecular Targets and Cancer Therapeutics, Munich, Germany, 29 November-2 December 2016
| Presentation Conference Type | Conference Paper (published) |
|---|---|
| Conference Name | 28 EORTC – NCI – AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Online Publication Date | Dec 9, 2016 |
| Publication Date | 2016-12 |
| Deposit Date | Jun 12, 2023 |
| Journal | European Journal of Cancer |
| Print ISSN | 0959-8049 |
| Publisher | Elsevier |
| Peer Reviewed | Peer Reviewed |
| Volume | 69 |
| Issue | S1 |
| Pages | S20 |
| DOI | https://doi.org/10.1016/s0959-8049%2816%2932640-5 |
| Keywords | Cancer Research; Oncology |
| Public URL | https://keele-repository.worktribe.com/output/445393 |
You might also like
Ivermectin Augments the Anti-Cancer Activity of Pitavastatin in Ovarian Cancer Cells
(2023)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search